Our Team

ANTHONY BAJORAS
founder, managing director

Nearly 20 years ago, Anthony met a doctor looking for investors to help launch a promising cancer therapy. That experience woke him to the immense challenge facing the mission to eliminate cancer: not funding for research, but investors willing to take significant financial risks, and possibly benefit from the rewards of supporting cancer innovations. It took losing his father to cancer, and starting his own family, to motivate Anthony to launch CANCER FUND, wanting more options and better outcomes for his own kids should they be diagnosed with cancer someday.

Anthony is the Founder of CANCER FUND and Managing Director of CANCER FUND I. He has 20+ years of experience building early-stage ventures, taking several from concept through exit. His advisory, consulting, and executive experience includes work with medical device, pharmaceutical, bioinformatics, wellness, and healthcare IT/ IoT companies. Anthony earned his BS in Business Management & Entrepreneurship from DePaul University adding non-degree undergraduate and graduate studies in design, engineering, and business from ASU, Illinois Institute of Technology, and Northwestern University.

ANN LOW
co-founder, The Lowdown on Cancer host

Ann is a serial entrepreneur, author, and cancer advocate. After her own cancer diagnosis in 2014, Ann, who spent several decades as a surgical assistant to a glaucoma specialist, recognized how little she knew about the cancer journey, even with her vast medical background. This raised a question in her mind, “If I found the experience difficult, what must it be like to have no medical background and receive a cancer diagnosis?” This question was the impetus for her to pen, Holy Crap I Have Cancer! Now What? What to Expect When You Weren’t Expecting, a book that assists patients, who are newly diagnosed with cancer through their treatment and into survivorship.

Prior to joining the CANCER FUND, Ann spent nearly a decade as the Executive Director of a Phoenix based non-profit, Hearts of Stone, whose mission is “to develop entrepreneurism in at-risk children and to transform the organizations that support them.” Ann was drawn to the CANCER FUND’s mission to invest in only early stage cancer innovations and hopes to join forces with like-minded individuals driven to have a real impact on cancer. Besides her advocacy, Ann is a mom, wife, and caregiver to her elderly parents, and likes to dabble in several different mediums of art.

JEFF REA, MBA
co-founder, stakeholder engagement

Jeff’s personal interest in cancer took root during college when his father fell to lung cancer and this interest was rekindled while developing and launching Athena bottled water benefiting women’s cancer research. Jeff and his wife relocated to Phoenix in 2017 after fledging their youngest child and he became involved in the area’s medical technology scene leading a new start-up, which eventually led him to CANCER FUND.  As a CANCER FUND co-founder, Jeff wears multiple hats but professes a particular interest in engaging our stakeholders – our community, investors, and innovators.

Professionally, Jeff is a Fortune 50 executive turned entrepreneur with a passion for early-stage ventures. After 15 years holding domestic and international responsibility for some of the world’s largest and most trusted consumer brands, Jeff helped launch a variety of start-ups in sectors ranging from entertainment to media to consumer products. Jeff has his MBA from the Kellogg School at Northwestern University and a BBA from Washington State University.

JAKE SNYDER
co-founder, venture studio

Over the 2010 – 2020 decade, Jake watched as his grandmother battled recurrence after recurrence of cancer, always refusing chemotherapy and other non-naturopathic treatments. She passed peacefully with her family in 2020, but continues to be a source of inspiration to him.

Jake is a native of Phoenix, Arizona and a graduate of the Biomedical Engineering program at Arizona State University. Growing up, he was passionate about capital markets and often spent time learning the principles of investing from his father. He realized early in his career as an orthopedic engineer that to create the impact he wanted to see in health innovation, he needed to take a risk. BIG risks. He gave his two week notice and moved from Indiana back home to the Valley, where he soon met the CANCER FUND team and immediately put his skills and experience to work supporting the back office operations of the fund and managing the CANCER FUND Venture Studios program. When not helping to build start-ups, he enjoys reading about history and exciting new technologies,  as well as training for triathlons.

PRASHANTH KINI, PhD
venture partner

Prashanth recently watched a close relative suffer through cancer, seemingly beating the disease with one of the most advanced therapies in the market, only to succumb to other conditions triggered by the disease. This experience reinforced for Prashanth that, despite the tremendous progress in the fight against cancer, there is much work to be done to better understand the complex disease and its nuances and to accelerate novel therapies. Prashanth was drawn to the CANCER FUND’s key mission to bridge the funding gap for early innovators while empowering individual investors to vote with and invest their funds for impact

Prashanth has spent the majority of his 25+ years career focused on healthcare and life sciences technology, holding product and business development executive leadership roles in fortune 50 companies and startups. Prashanth spent the last few years in private equity in investor/operating roles including working with portfolio companies focused on leveraging oncology Real World Data in clinical development through commercialization of therapies. Prashanth is an early stage investor across multiple funds and remains committed to providing his expertise toward advancing diagnostics, therapeutics, and care delivery technologies.

Prashanth earned his PhD in Electrical and Computer Engineering from the University of Cincinnati with his dissertation focused on novel skin imaging approaches for the detection and assessment of skin cancer. He has lived and learned across three different continents and now delights in the endless natural beauty of the San Francisco Bay Area with his wife, daughter and two furry 4-legged family members.

AVI DUKLER, PhD
venture partner

Avi’s journey into the realm of cancer research and impact investment has been both recent and profound. While his parents’ survival stories from cancer were due to early diagnoses and effective treatments, the true impact of these experiences came to light over time.

For the past 25 years, Avi has been a dedicated professional in the healthtech industry, with a primary focus on inflammation and autoimmunity. In 2022, he ventured into new territory, advising two early-stage startups with a specific focus on oncology. His contributions ranged from market landscape analysis to shaping robust business and go-to-market strategies for these ventures. This experience not only exposed him to the remarkable technological advancements in cancer but also underscored the continuous need for innovations, new business models, and enhanced patient access.

However, it was a deeply personal turn of events in early 2023, when Avi became a caregiver for a close family member battling cancer, that ignited his sense of mission and purpose.

Avi is a seasoned entrepreneur, having founded biotech and clinical diagnostics companies. His executive roles within these organizations, coupled with his advisory roles in numerous early-stage companies, have equipped him with extensive expertise in fundraising across private and public markets, product development, clinical operations, regulatory affairs, reimbursement strategies, and commercialization.

Avi earned his Ph.D. in biotechnology from Tel-Aviv University and boasts an impressive portfolio of scientific publications and patents in the field of diagnostics.

JOHN ANAGNOSTIS
venture partner

John’s first exposure to cancer came as a teenager, watching his mother battle breast cancer through his high school years. Breast Cancer incidence runs extremely high for the women in his family, and over the years he has lost several aunts and cousins to the disease, while watching others, including his mother, suffer through the deleterious physical and mental side effects that come with cancer treatment.

Nearly a decade ago, John lost a dear friend to breast cancer who was unaware she had it until it was ‘too late’, due to a lack of access to proper prevention and treatment care, something that happens all too often. It is one of the reasons he supports organizations like the Connie Dwyer Breast Center, which provides free breast care to uninsured and underserved women, and what drew him to the impact-oriented nature of Cancer Fund.

John comes from an economics and finance background, starting his career in retail real estate strategy and alternative investments before moving into venture capital. He has ten years of venture experience investing in companies from seed to D stages and advising portfolio companies post-investment. He has worked on deals throughout the Americas, Europe, and Africa across a variety of business verticals. John is a native of New Jersey, but his home away from home is Italy. In addition to living in Italy several times throughout his life, John also received his MBA from Sda Bocconi in Milan. John is a former collegiate tennis player and still loves to play tennis whenever he has the time, as well as go skiing, though he is better known for his après ski abilities.

JENNIFER LEE
venture partner

Transformed by a personal tragedy in which she lost loved ones to cancer, Jennifer has dedicated two decades to guiding companies in turning cutting-edge science into life-saving treatments. As a part of CANCER FUND, she contributes her expertise to their unique mission of improving patient outcomes, expanding healthcare access, and reducing care costs.

With a strong track record of expediting breakthrough therapies, Jennifer has contributed to the FDA approvals of seven novel therapies, generating $20 billion in value. Her work has facilitated millions in savings, global approvals, licensing deals, and business exits.
An investor and STEM advocate, she focuses her investments on companies advancing science and technology for global impact. Jennifer is also dedicated to reducing digital data waste.

Jennifer serves on multiple private and non-profit boards and is a published author in esteemed medical and scientific journals and industry blogs. A respected speaker, she holds a bachelor’s degree in Biochemistry from the University of Illinois and a master’s in Regulatory Compliance from Northwestern University.

EDWARD CHO, PhD
venture partner

Ed has spent the past 20+ years as a cancer researcher, life sciences leader, and entrepreneur. He devoted his career to building personalized medicine technologies because each cancer is as unique as the person whose life it disrupts.

Ed is the Head of Biologics Development at Detect, Inc., a molecular diagnostics startup delivering at-home lab-quality tests. He is also Co-Founder/Chief Scientific Officer at Spin Bio, a life sciences startup building a novel single cell analysis platform. He previously co-founded several other life sciences startups. Ed consults for, advises, and mentors other life sciences startups and volunteers as a Board Member for STEM education focused nonprofits. Ed is excited to join the motivated team at CANCER FUND and looks forward to helping the team invest in innovative companies at the forefront of fighting cancer.

Ed received his Bachelors in Public Health and Masters in Biotechnology from Johns Hopkins University, his PhD in Molecular Medicine/Cancer Biology from the University of Maryland Baltimore, and did his Postdoctoral Fellowship at Scripps Research. As an entrepreneur, he has first-hand experience of the problem that Cancer Fund is solving: progressing high-risk, breakthrough cancer diagnostic and treatment innovations BEYOND RESEARCH due to lack of funding.

Join Our Team

YOUR NAME HERE
venture partner

Interested in joining CANCER FUND? We’re looking for passionate people to help grow our investor community, expand and evaluate our innovation pipeline, and help manage our portfolio. Click here to learn more about our Venture Partner role.

YOUR NAME HERE
ambassador

Interested in joining CANCER FUND? We’re looking for cancer survivors, patients, caregivers, and friends and family that share our passion to support cancer innovations. Click to learn more about our breast cancer ambassador and men’s cancer ambassador roles or contact us below to discuss other ambassador roles.

YOUR NAME HERE
ovarian cancer / prostate cancer advisors

We are seeking qualified advisors to help advise our team for our upcoming ovarian and prostate cancer investment cycles. Click here to learn more about this role.

YOUR NAME HERE
screening committee member

If you are passionate about cancer and innovation, we invite you to join our virtual screening committee to help us select our investments.

YOUR NAME HERE
investment committee member

If you’re an experienced early-stage investor, angel investor, proven founder, or executive in our space and want to have a real impact by helping guide our investment decisions, let’s talk.

YOUR NAME HERE
intern

If you are passionate about cancer and interested in starting a career in venture capital, an internship at CANCER FUND might be right for you. Available opportunities include Venture Capital Associate Intern, Venture Analyst Intern, and Operations Analyst Intern. Click the links for more information on the positions. 

Apply by clicking the button below.

Join Our Virtual Screening Committee
Celebrate You Hero